S. schenckii, S. luriei, S. brasiliensis e S. albicans: suscetibilidade a agentes antifúngicos combinados e caracterização de perfil enzimático

Detalhes bibliográficos
Autor(a) principal: Oliveira, Daniele Carvalho de
Data de Publicação: 2012
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Biblioteca Digital de Teses e Dissertações do UFSM
Texto Completo: http://repositorio.ufsm.br/handle/1/27140
Resumo: Recently was proposed that Sporothrix schenckii is a complex encompassing six cryptic species, which calls for the reassessment of laboratory characteristics inherent susceptibility and virulence of this fungi complex. In these contexts, the aim of this study was to evaluate the in vitro susceptibility of Sporothrix albicans, S. brasiliensis, S. luriei and S. schenckii to terbinafine in combination with itraconazole, ketoconazole and voriconazole as well as the correlation of enzymatic profile with the new species. The isolates (n=40) were from cases of human (18 isolates from cases of fixed cutaneous sporotrichosis and 13 isolates from cases of lymphocutaneous sporotrichosis), feline (n = 8) and canine (n=1) sporotrichosis and were previously identified by phenotypic and molecular tests. The assessment of the susceptibility was performed based on the protocol M38-A2 and the enzymatic activity was determined using the commercial kit API-ZYM System (BioMérieux, Marcy- l’Etoile, France) in accordance with the manufacturer’s instructions. In assessing the susceptibility, synergism was observed in only one isolate (2,5%) of the association of TRB+CTZ; addition, in the 11 (27,5%) strain tested for TRB+CTZ; in TRB+ITZ 14 (35%) of isolates and in TRB+VRC. Most interactions were indifferent. The Sporothrix schenckii Complex had different positive results for each of the new species tested. Enzymes such as esterase, esterase lipase, acid phosphatase, naphthol-AS-BI-phosphohydrolase and β-glucosidase were recorded as positive reaction in 85 – 97,5% of strains. Among the different enzymatic profiles obtained, there was unique and very peculiar to the new specimens, the positive it was observed that positive reactions for lipase and leucine arilamidase were documented only for S. brasiliensis and S. albicans, respectively. Furthermore, only S. luriei species was recorded as negative reaction for naphthol-AS-BI-phosphohydrolase. Furthmore, only S. luriei obtained negative result for naphthol-AS-BI-phosphohydrolase. The 37 isolated of S. schenckii were tested featured in 15 different biotypes. The variability enzyme found may contributes to a better understanding to the differences in virulence and resistance among species of the genus Sporothrix, and may possibility a new phenotypic basis for separating and classify the new specie, as well as providing a review of clinical and epidemiological data of sporotrichosis.
id UFSM_da2dc3c08f3d9ef82f115de19e5cb8b8
oai_identifier_str oai:repositorio.ufsm.br:1/27140
network_acronym_str UFSM
network_name_str Biblioteca Digital de Teses e Dissertações do UFSM
repository_id_str
spelling 2022-11-29T17:50:13Z2022-11-29T17:50:13Z2012-08-06http://repositorio.ufsm.br/handle/1/27140Recently was proposed that Sporothrix schenckii is a complex encompassing six cryptic species, which calls for the reassessment of laboratory characteristics inherent susceptibility and virulence of this fungi complex. In these contexts, the aim of this study was to evaluate the in vitro susceptibility of Sporothrix albicans, S. brasiliensis, S. luriei and S. schenckii to terbinafine in combination with itraconazole, ketoconazole and voriconazole as well as the correlation of enzymatic profile with the new species. The isolates (n=40) were from cases of human (18 isolates from cases of fixed cutaneous sporotrichosis and 13 isolates from cases of lymphocutaneous sporotrichosis), feline (n = 8) and canine (n=1) sporotrichosis and were previously identified by phenotypic and molecular tests. The assessment of the susceptibility was performed based on the protocol M38-A2 and the enzymatic activity was determined using the commercial kit API-ZYM System (BioMérieux, Marcy- l’Etoile, France) in accordance with the manufacturer’s instructions. In assessing the susceptibility, synergism was observed in only one isolate (2,5%) of the association of TRB+CTZ; addition, in the 11 (27,5%) strain tested for TRB+CTZ; in TRB+ITZ 14 (35%) of isolates and in TRB+VRC. Most interactions were indifferent. The Sporothrix schenckii Complex had different positive results for each of the new species tested. Enzymes such as esterase, esterase lipase, acid phosphatase, naphthol-AS-BI-phosphohydrolase and β-glucosidase were recorded as positive reaction in 85 – 97,5% of strains. Among the different enzymatic profiles obtained, there was unique and very peculiar to the new specimens, the positive it was observed that positive reactions for lipase and leucine arilamidase were documented only for S. brasiliensis and S. albicans, respectively. Furthermore, only S. luriei species was recorded as negative reaction for naphthol-AS-BI-phosphohydrolase. Furthmore, only S. luriei obtained negative result for naphthol-AS-BI-phosphohydrolase. The 37 isolated of S. schenckii were tested featured in 15 different biotypes. The variability enzyme found may contributes to a better understanding to the differences in virulence and resistance among species of the genus Sporothrix, and may possibility a new phenotypic basis for separating and classify the new specie, as well as providing a review of clinical and epidemiological data of sporotrichosis.Recentemente foi proposto que Sporothrix schenckii é um complexo que engloba seis espécies, o que exige a reavaliação das características laboratoriais inerentes à suscetibilidade e à virulência desse complexo fúngico. Neste contexto, o objetivo deste estudo foi avaliar a suscetibilidade in vitro de 40 isolados de Sporothrix albicans, S. brasiliensis, S. luriei e S. schenckii à terbinafina (TER) em combinação com itraconazol (ITZ), cetoconazol (CTZ) e voriconazol (VRC), bem como investigar o perfil enzimático destas novas espécies. Os isolados são oriundos de esporotricose em humanos (18 da forma cutânea fixa e 13 isolados da forma linfocutânea), de felinos (n = 8) e de canino (n = 1), tendo sido previamente identificados por testes fenotípicos e moleculares. A avaliação da suscetibilidade foi realizada com base no protocolo M38-A2 (CLSI) e a atividade enzimática foi determinada através do Sistema API-ZYM® (bioMérieux, Marcy-l'Etoile, França). Na avaliação da suscetibilidade aos antifúngicos combinados, a interação sinérgica só foi verificada pela associação TRB+ITZ, ocorrendo somente frente a um isolado da espécie S. schenckii; a mesma combinação evidenciou efeito aditivo frente a 14 (35%) isolados. Já as combinações TRB+CTZ e TRB+VRC apresentaram efeito aditivo para 11 [27,535%] e 1 [2,5%] isolados, respectivamente. Todas as demais combinações evidenciaram interações indiferentes. Em relação ao perfil enzimático, as enzimas esterase, lipase esterase, fosfatase ácida, naftol-AS-BI-phosphohydrolase e β-glucosidase foram caracterizadas em 85 - 97,5% dos isolados estudados. A enzima lipase só foi detectada em S. brasiliensis enquanto que a leucino-arilamidase somente ocorreu em S. albicans. a ausência de naftol-as-bi-phosphohydrolase só ocorreu em S. luriei. Os 37 isolados identificados como S. schenckii manifestaram variações enzimáticas que permitiram agrupar estes isolados em 15 diferentes biotipos. O estudo do perfil enzimático em espécies recentemente identificadas é importante, pois, vem contribuir com a compreensão da virulência, suscetibilidade e, sobretudo, pode oportunizar novas possibiliades para identificar, separar e classificar fenotipicamente as novas espécies de agentes da esporotricose.porUniversidade Federal de Santa MariaCentro de Ciências da SaúdePrograma de Pós-Graduação em FarmacologiaUFSMBrasilFarmacologiaAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessSporothrix sppSuscetibilidadeAssociaçõesPerfil enzimáticoVirulênciaEnzymeProfileSynergismAntifungal associationCNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIAS. schenckii, S. luriei, S. brasiliensis e S. albicans: suscetibilidade a agentes antifúngicos combinados e caracterização de perfil enzimáticoS. schenckii, S. luriei, S. brasiliensis e S. albicans: susceptibilities to combinatorial antifungal agents and characterization of enzymatic profilesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisAlves, Sydney Hartzhttp://lattes.cnpq.br/0330782478769631Moreira, Cleci MenezesPereira, Daniela Isabel BrayerRolim, Clarice Madalena BuenoSanturio, Janio Moraishttp://lattes.cnpq.br/4817827751698191Oliveira, Daniele Carvalho de201000000000600600600600600600600bfe6016c-9c1e-42ca-ab1d-db5453ed090cecc44c45-1ac6-4b86-8d30-9c7484cb2f6742b89fc7-1153-4da6-b5b3-8f2f688fad00d09ffaf4-4202-45bc-9969-4464c5afe88af07277f6-4089-4ba0-ad2d-6c5c002cdf2ae986af4d-eede-46ca-bc5d-a5c3064811abreponame:Biblioteca Digital de Teses e Dissertações do UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSMLICENSElicense.txtlicense.txttext/plain; charset=utf-81956http://repositorio.ufsm.br/bitstream/1/27140/3/license.txt2f0571ecee68693bd5cd3f17c1e075dfMD53ORIGINALTES_PPGFARMACOLOGIA_2012_OLIVEIRA_DANIELE.pdfTES_PPGFARMACOLOGIA_2012_OLIVEIRA_DANIELE.pdfTese de doutoradoapplication/pdf1837418http://repositorio.ufsm.br/bitstream/1/27140/4/TES_PPGFARMACOLOGIA_2012_OLIVEIRA_DANIELE.pdf0491e2a4b0464f408e423c76ef039236MD54CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805http://repositorio.ufsm.br/bitstream/1/27140/2/license_rdf4460e5956bc1d1639be9ae6146a50347MD521/271402022-11-30 12:16:20.789oai:repositorio.ufsm.br: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 Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2022-11-30T15:16:20Biblioteca Digital de Teses e Dissertações do UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.por.fl_str_mv S. schenckii, S. luriei, S. brasiliensis e S. albicans: suscetibilidade a agentes antifúngicos combinados e caracterização de perfil enzimático
dc.title.alternative.eng.fl_str_mv S. schenckii, S. luriei, S. brasiliensis e S. albicans: susceptibilities to combinatorial antifungal agents and characterization of enzymatic profiles
title S. schenckii, S. luriei, S. brasiliensis e S. albicans: suscetibilidade a agentes antifúngicos combinados e caracterização de perfil enzimático
spellingShingle S. schenckii, S. luriei, S. brasiliensis e S. albicans: suscetibilidade a agentes antifúngicos combinados e caracterização de perfil enzimático
Oliveira, Daniele Carvalho de
Sporothrix spp
Suscetibilidade
Associações
Perfil enzimático
Virulência
Enzyme
Profile
Synergism
Antifungal association
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
title_short S. schenckii, S. luriei, S. brasiliensis e S. albicans: suscetibilidade a agentes antifúngicos combinados e caracterização de perfil enzimático
title_full S. schenckii, S. luriei, S. brasiliensis e S. albicans: suscetibilidade a agentes antifúngicos combinados e caracterização de perfil enzimático
title_fullStr S. schenckii, S. luriei, S. brasiliensis e S. albicans: suscetibilidade a agentes antifúngicos combinados e caracterização de perfil enzimático
title_full_unstemmed S. schenckii, S. luriei, S. brasiliensis e S. albicans: suscetibilidade a agentes antifúngicos combinados e caracterização de perfil enzimático
title_sort S. schenckii, S. luriei, S. brasiliensis e S. albicans: suscetibilidade a agentes antifúngicos combinados e caracterização de perfil enzimático
author Oliveira, Daniele Carvalho de
author_facet Oliveira, Daniele Carvalho de
author_role author
dc.contributor.advisor1.fl_str_mv Alves, Sydney Hartz
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/0330782478769631
dc.contributor.referee1.fl_str_mv Moreira, Cleci Menezes
dc.contributor.referee2.fl_str_mv Pereira, Daniela Isabel Brayer
dc.contributor.referee3.fl_str_mv Rolim, Clarice Madalena Bueno
dc.contributor.referee4.fl_str_mv Santurio, Janio Morais
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/4817827751698191
dc.contributor.author.fl_str_mv Oliveira, Daniele Carvalho de
contributor_str_mv Alves, Sydney Hartz
Moreira, Cleci Menezes
Pereira, Daniela Isabel Brayer
Rolim, Clarice Madalena Bueno
Santurio, Janio Morais
dc.subject.por.fl_str_mv Sporothrix spp
Suscetibilidade
Associações
Perfil enzimático
Virulência
topic Sporothrix spp
Suscetibilidade
Associações
Perfil enzimático
Virulência
Enzyme
Profile
Synergism
Antifungal association
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
dc.subject.eng.fl_str_mv Enzyme
Profile
Synergism
Antifungal association
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
description Recently was proposed that Sporothrix schenckii is a complex encompassing six cryptic species, which calls for the reassessment of laboratory characteristics inherent susceptibility and virulence of this fungi complex. In these contexts, the aim of this study was to evaluate the in vitro susceptibility of Sporothrix albicans, S. brasiliensis, S. luriei and S. schenckii to terbinafine in combination with itraconazole, ketoconazole and voriconazole as well as the correlation of enzymatic profile with the new species. The isolates (n=40) were from cases of human (18 isolates from cases of fixed cutaneous sporotrichosis and 13 isolates from cases of lymphocutaneous sporotrichosis), feline (n = 8) and canine (n=1) sporotrichosis and were previously identified by phenotypic and molecular tests. The assessment of the susceptibility was performed based on the protocol M38-A2 and the enzymatic activity was determined using the commercial kit API-ZYM System (BioMérieux, Marcy- l’Etoile, France) in accordance with the manufacturer’s instructions. In assessing the susceptibility, synergism was observed in only one isolate (2,5%) of the association of TRB+CTZ; addition, in the 11 (27,5%) strain tested for TRB+CTZ; in TRB+ITZ 14 (35%) of isolates and in TRB+VRC. Most interactions were indifferent. The Sporothrix schenckii Complex had different positive results for each of the new species tested. Enzymes such as esterase, esterase lipase, acid phosphatase, naphthol-AS-BI-phosphohydrolase and β-glucosidase were recorded as positive reaction in 85 – 97,5% of strains. Among the different enzymatic profiles obtained, there was unique and very peculiar to the new specimens, the positive it was observed that positive reactions for lipase and leucine arilamidase were documented only for S. brasiliensis and S. albicans, respectively. Furthermore, only S. luriei species was recorded as negative reaction for naphthol-AS-BI-phosphohydrolase. Furthmore, only S. luriei obtained negative result for naphthol-AS-BI-phosphohydrolase. The 37 isolated of S. schenckii were tested featured in 15 different biotypes. The variability enzyme found may contributes to a better understanding to the differences in virulence and resistance among species of the genus Sporothrix, and may possibility a new phenotypic basis for separating and classify the new specie, as well as providing a review of clinical and epidemiological data of sporotrichosis.
publishDate 2012
dc.date.issued.fl_str_mv 2012-08-06
dc.date.accessioned.fl_str_mv 2022-11-29T17:50:13Z
dc.date.available.fl_str_mv 2022-11-29T17:50:13Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/27140
url http://repositorio.ufsm.br/handle/1/27140
dc.language.iso.fl_str_mv por
language por
dc.relation.cnpq.fl_str_mv 201000000000
dc.relation.confidence.fl_str_mv 600
600
600
600
600
600
600
dc.relation.authority.fl_str_mv bfe6016c-9c1e-42ca-ab1d-db5453ed090c
ecc44c45-1ac6-4b86-8d30-9c7484cb2f67
42b89fc7-1153-4da6-b5b3-8f2f688fad00
d09ffaf4-4202-45bc-9969-4464c5afe88a
f07277f6-4089-4ba0-ad2d-6c5c002cdf2a
e986af4d-eede-46ca-bc5d-a5c3064811ab
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Centro de Ciências da Saúde
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Farmacologia
dc.publisher.initials.fl_str_mv UFSM
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Farmacologia
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Centro de Ciências da Saúde
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações do UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Biblioteca Digital de Teses e Dissertações do UFSM
collection Biblioteca Digital de Teses e Dissertações do UFSM
bitstream.url.fl_str_mv http://repositorio.ufsm.br/bitstream/1/27140/3/license.txt
http://repositorio.ufsm.br/bitstream/1/27140/4/TES_PPGFARMACOLOGIA_2012_OLIVEIRA_DANIELE.pdf
http://repositorio.ufsm.br/bitstream/1/27140/2/license_rdf
bitstream.checksum.fl_str_mv 2f0571ecee68693bd5cd3f17c1e075df
0491e2a4b0464f408e423c76ef039236
4460e5956bc1d1639be9ae6146a50347
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações do UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1791086180757929984